Sean Dodge
Stock Analyst at RBC Capital
(2.18)
# 2,900
Out of 5,044 analysts
131
Total ratings
37.11%
Success rate
-1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean Dodge
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HCAT Health Catalyst | Maintains: Sector Perform | $7 → $6 | $3.38 | +77.51% | 10 | Feb 27, 2025 | |
| AGL agilon health | Maintains: Outperform | $3 → $3.5 | $0.91 | +283.14% | 7 | Feb 26, 2025 | |
| IQV IQVIA Holdings | Reiterates: Outperform | $270 | $218.13 | +23.78% | 6 | Feb 10, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $11 → $12 | $8.36 | +43.54% | 16 | Jan 24, 2025 | |
| ICLR ICON Public Limited Company | Reiterates: Outperform | $263 | $177.73 | +47.98% | 2 | Jan 15, 2025 | |
| EVH Evolent Health | Maintains: Outperform | $20 → $17 | $7.41 | +129.42% | 9 | Jan 14, 2025 | |
| PHR Phreesia | Upgrades: Outperform | $24 → $32 | $23.41 | +36.69% | 15 | Jan 8, 2025 | |
| OPRX OptimizeRx | Downgrades: Sector Perform | $7 → $6 | $21.04 | -71.48% | 11 | Jan 8, 2025 | |
| HQY HealthEquity | Maintains: Outperform | $100 → $105 | $95.15 | +10.35% | 12 | Dec 10, 2024 | |
| SHC Sotera Health Company | Reiterates: Outperform | $17 | $16.56 | +2.66% | 10 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $34 | $39.49 | -13.90% | 2 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $19.52 | -28.28% | 3 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $3.66 | +173.22% | 12 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $28 | $25.93 | +7.98% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $14 | $19.23 | -27.20% | 13 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $33 | $180.25 | -81.69% | 1 | Sep 14, 2022 |
Health Catalyst
Feb 27, 2025
Maintains: Sector Perform
Price Target: $7 → $6
Current: $3.38
Upside: +77.51%
agilon health
Feb 26, 2025
Maintains: Outperform
Price Target: $3 → $3.5
Current: $0.91
Upside: +283.14%
IQVIA Holdings
Feb 10, 2025
Reiterates: Outperform
Price Target: $270
Current: $218.13
Upside: +23.78%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $11 → $12
Current: $8.36
Upside: +43.54%
ICON Public Limited Company
Jan 15, 2025
Reiterates: Outperform
Price Target: $263
Current: $177.73
Upside: +47.98%
Evolent Health
Jan 14, 2025
Maintains: Outperform
Price Target: $20 → $17
Current: $7.41
Upside: +129.42%
Phreesia
Jan 8, 2025
Upgrades: Outperform
Price Target: $24 → $32
Current: $23.41
Upside: +36.69%
OptimizeRx
Jan 8, 2025
Downgrades: Sector Perform
Price Target: $7 → $6
Current: $21.04
Upside: -71.48%
HealthEquity
Dec 10, 2024
Maintains: Outperform
Price Target: $100 → $105
Current: $95.15
Upside: +10.35%
Sotera Health Company
Nov 21, 2024
Reiterates: Outperform
Price Target: $17
Current: $16.56
Upside: +2.66%
Nov 7, 2024
Maintains: Outperform
Price Target: $31 → $34
Current: $39.49
Upside: -13.90%
Sep 17, 2024
Reiterates: Outperform
Price Target: $14
Current: $19.52
Upside: -28.28%
Aug 16, 2024
Reiterates: Outperform
Price Target: $10
Current: $3.66
Upside: +173.22%
Aug 14, 2024
Reiterates: Outperform
Price Target: $28
Current: $25.93
Upside: +7.98%
Jul 25, 2024
Maintains: Outperform
Price Target: $15 → $14
Current: $19.23
Upside: -27.20%
Sep 14, 2022
Initiates: Outperform
Price Target: $33
Current: $180.25
Upside: -81.69%